Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Carboplatin/pemetrexed/osimertinib

Neutropenia and aplastic anaemia

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Abdalhadi A, et al. Aplastic anemia secondary to adjuvant Osimertinib therapy: a case report and a review of literature. Frontiers in Oncology 14: Jan 2024. Available from: URL: https://dx.doi.org/10.3389/fonc.2024.1275275 Abdalhadi A, et al. Aplastic anemia secondary to adjuvant Osimertinib therapy: a case report and a review of literature. Frontiers in Oncology 14: Jan 2024. Available from: URL: https://​dx.​doi.​org/​10.​3389/​fonc.​2024.​1275275
Metadaten
Titel
Carboplatin/pemetrexed/osimertinib
Neutropenia and aplastic anaemia
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56058-3

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Interferon

Case report

Adalimumab

Case report

Esmolol

Case report

Multiple drugs